Milestone Pharmaceuticals Inc. financial data

Symbol
MIST on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Boul. Dr. Frederik Philips, Ste 420, Montreal, Quebec, Canada
State of incorporation
Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.58K % +27.8%
Debt-to-equity 205 % +114%
Return On Equity -152 % -21.2%
Return On Assets -49.9 % +22.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.3M shares +59.3%
Common Stock, Shares, Outstanding 53.3M shares +59.3%
Entity Public Float 95.9M USD -48%
Common Stock, Value, Issued 288M USD +10.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.9M USD -56.1%
General and Administrative Expense 16.1M USD -3.43%
Operating Income (Loss) -43.6M USD +28.7%
Net Income (Loss) Attributable to Parent -42.8M USD +27.8%
Earnings Per Share, Basic -0.81 USD/shares +41.7%
Earnings Per Share, Diluted -0.81 USD/shares +41.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.8M USD +29.6%
Cash, Cash Equivalents, and Short-term Investments 76.4M USD +0.93%
Assets, Current 81M USD -4.49%
Property, Plant and Equipment, Net 201K USD -26.1%
Operating Lease, Right-of-Use Asset 1.52M USD -26%
Assets 82.7M USD -5.06%
Employee-related Liabilities, Current 1.99M USD -18%
Liabilities, Current 5.26M USD -35.2%
Operating Lease, Liability, Noncurrent 1M USD -36.7%
Liabilities 58.7M USD +0.14%
Retained Earnings (Accumulated Deficit) -355M USD -13.7%
Stockholders' Equity Attributable to Parent 24M USD -15.8%
Liabilities and Equity 82.7M USD -5.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.93M USD +35.7%
Net Cash Provided by (Used in) Financing Activities 32.3M USD -35.7%
Net Cash Provided by (Used in) Investing Activities -27M USD -190%
Common Stock, Shares, Issued 53.3M shares +59.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.63M USD -105%
Deferred Tax Assets, Valuation Allowance 80.2M USD +21.7%
Deferred Tax Assets, Gross 80.2M USD +21.7%
Operating Lease, Liability 2M USD -19.6%
Payments to Acquire Property, Plant, and Equipment 32K USD
Lessee, Operating Lease, Liability, to be Paid 2.28M USD -22.2%
Property, Plant and Equipment, Gross 468K USD +24.1%
Operating Lease, Liability, Current 582K USD +9.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 670K USD +0.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 673K USD +2.44%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276K USD -37%
Lessee, Operating Lease, Liability, to be Paid, Year Three 530K USD -20.5%
Deferred Tax Assets, Operating Loss Carryforwards 66.7M USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 406K USD -23.4%
Additional Paid in Capital 38.1M USD +19.3%
Depreciation, Depletion and Amortization 28K USD +55.6%
Share-based Payment Arrangement, Expense 6.18M USD -36.9%
Interest Expense 3.39M USD +2542%